Worcester Biomanufacturing Project Put on Hold
The facility expansion had been planned by a contract drug manufacturing company that’s under scrutiny by Congress amid concerns about security of genomic data.
Beacon Hill OKs New Frontiers for Devens Growth
Legislators’ decision to approve 3.5 million square feet of development at Devens is set to bring a new pulse of growth to the former Army base-turned-business-park.
Berkeley Investments Targets Drug Manufacturing Growth in Billerica
A 203,000-square-foot development by Berkeley Investments seeks to tap into demand for biomanufacturing facilities in the northern suburbs.
Berkeley Investments Plans GMP Development in Billerica
Billerica manufacturer Cabot Corp. is maximizing the value of its real estate with the sale of an adjacent parcel for a biomanufacturing plant to be developed by Boston-based Berkeley Investments.
Burlington Life Science Project Targets Fall Groundbreaking
Nordblom Co. plans to break ground in November on a new 270,000-square-foot R&D and biomanufacturing development at its 141-acre Network Drive campus in Burlington.
No Lab Rent Relief Seen Before 2023
A projected 18 million square feet of lab space is scheduled for completion in Greater Boston in 2023, potentially tempering the skyrocketing rent increases being driven by the life science industry’s space demand.
Nordblom Proposes Biomanufacturing on Burlington Campus
Nordblom Co. is seeking to build a 270,000-square-foot life science and biomanufacturing complex at a Burlington site where it had unsuccessfully marketed a build-to-suit office building in recent years.
Vote Now for B&T’s Best of 2024!
